Thousands of new immune system signals have been uncovered with potential implications for immunotherapy, autoimmune diseases and vaccine development.
The researchers behind the finding say it is the biological equivalent of discovering a new continent.
It’s as if a geographer would tell you they had discovered a new continent, or an astronomer would say they had found a new planet in the solar system. And just as with those discoveries, we have a lot of exploring to do.– Professor Michael Stumpf
Our cells regularly break down proteins from our own bodies and from foreign bodies, such as viruses and bacteria. Small fragments of these proteins, called epitopes, are displayed on the surface of the cells like little flags so that the immune system can scan them. If they are recognised as foreign, the immune system will destroy the cell to prevent the spread of infection.
In a new study, researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
These spliced epitopes were thought to be rare, but the scientists have now identified thousands of them by developing a new method that allowed them to map the surface of cells and identify a myriad of previously unknown epitopes.
The findings should help scientists to better understand the immune system, including autoimmune diseases, as well as provide potential new targets for immunotherapy and vaccine design.
DEEPER UNDERSTANDING
The research was led by Dr Juliane Liepe from Imperial College London and Dr Michele Mishto from Charité – Universitätsmedizin Berlin in Germany in collaboration with the LaJolla Institute for Allergy and Immunology and Utrecht University, and it is published today in Science.
Co-author of the study Professor Michael Stumpf from the Department of Life Sciences at Imperial said: “It’s as if a geographer would tell you they had discovered a new continent, or an astronomer would say they had found a new planet in the solar system.
“And just as with those discoveries, we have a lot of exploring to do. This could lead to not only a deeper understanding of how the immune system operates, but also suggests new avenues for therapies and drug and vaccine development.”
Prior to the new study, scientists thought that the machinery in a cell created signalling peptides by cutting fragments out of proteins in sequence, and displaying these in order on the surface of the cell.
However, this cell machinery can also create ‘spliced’ peptides by cutting two fragments from different positions in the protein and then sticking them together out of order, creating a new sequence.
Scientists knew about the existence of the spliced epitopes, but they were thought to be rare. The new study suggests that spliced epitopes actually make up a large proportion of signalling epitopes: they make up around a quarter of the overall number of epitopes, and account for 30-40 per cent of the diversity – the number of different kinds of epitopes.
PROS AND CONS
These extra epitopes give the immune system more to scan, and more possibilities of detecting disease. However, as the spliced epitopes are mixed sequences, they also have the potential to overlap with the sequences of healthy signallers and be misidentified as harmful.
This could help scientists understand autoimmune diseases, where the immune system turns against normal body tissues, such as in Type 1 diabetes and multiple sclerosis.
The study’s lead author, Dr Juliane Liepe from the Department of Life Sciences at Imperial, said: “The discovery of the importance of spliced peptides could present pros and cons when researching the immune system.
“For example, the discovery could influence new immunotherapies and vaccines by providing new target epitopes for boosting the immune system, but it also means we need to screen for many more epitopes when designing personalised medicine approaches.”
Learn more: Overlooked molecules could revolutionise our understanding of the immune system
The Latest on: Immune system
[google_news title=”” keyword=”immune system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immune system
- Gut Bacteria Boost Immune Response to Fight Tumors in Preclinical Studyon May 17, 2024 at 6:00 pm
“A proinflammatory intestinal environment coincided with expansion, increased circulation, and migration of TNF-producing CD4+ T cells to the tumor bed. Thus, TREM2 remotely controls anti–PD-1 immune ...
- Professional Faqs: What Happens In The Immune System Of Someone With Sarcoidosis?on May 17, 2024 at 2:28 pm
Expert opinion from Sarath Chandr Rellu MBBS · 2 years of experience · India People with sarcoidosis have hyperactive immune system that leads to widespread inflammation. The hallmark of sarcoidosis ...
- Smoking: long term damage to immune systemon May 17, 2024 at 12:26 am
Human bodies retain a long-term ‘memory’ from smoking which affects their defence against illness, according to research.
- Can Crohn’s Disease Compromise Your Immune System?on May 16, 2024 at 6:52 pm
Some experts believe that Crohn's disease is due to an overactive immune system, but not everyone supports this claim. Further research is needed.
- Research explains new method to engineer immune cells that could treat multiple cancer patientson May 16, 2024 at 8:20 am
Immunotherapies have revolutionized cancer treatment by harnessing the body's own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each ...
- What 11 Analyst Ratings Have To Say About Alpine Immune Scienceson May 16, 2024 at 6:11 am
Analysts have recently evaluated Alpine Immune Sciences and provided 12-month price targets. The average target is $54.0, accompanied by a high estimate of $65.00 and a low estimate of $41.00.
- Dear Doctor: Shingles outbreak happens due to immune system failure, not because of exposureon May 16, 2024 at 6:00 am
ANSWER: About 99% of North Americans are immune to the varicella-zoster virus that causes chicken pox and shingles, either because they had it as a child or because they got the vaccine. Exposure to ...
- Immunotherapy Could Be Used To Boost the Immune System of Older Individualson May 16, 2024 at 1:13 am
Immunotherapy could be used to enhance immune responses in older people, making them less vulnerable to infections, reports a new study.
- B cells drive responses of other immune cells, and can be modified to prevent Multiple Sclerosis symptomson May 15, 2024 at 5:00 pm
B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...
via Bing News